Perspectum, an Oxford, England-based precision health company developing medical imaging tools to improve the diagnosis of metabolic diseases and cancer, completed $36 million in the first close of its Series C funding round.
The round was led by Oppenheimer Holdings. With this, the total funding raised by the company accounts for $120 million.
The new funding will be used to scale up its US operations and accelerate its product pipeline for multiorgan inflammatory conditions and oncology.
“We are excited to have Oppenheimer and British Patient Capital join our mission to create safer and more accurate imaging technologies that will help clinicians shorten patients’ diagnostic and treatment journeys,” said Rajarshi Banerjee, MD, PhD, CEO of Perspectum. “This new funding will help us to continue innovating new products that will make healthcare safer by providing non-invasive alternatives to biopsy, totally changing how and when we can see and treat many diseases.”
Perspectum’s software products enhance the capabilities of a standard magnetic resonance imaging (MRI) machine, enabling it to capture multiparametric mapping data that allows its AI-driven software to measure organ inflammation with greater precision, aiding in the diagnosis and monitoring of patients with chronic diseases.
Company: Perspectum Ltd
Round: Series C
Funding Month: January 2023
Lead Investors: Oppenheimer Holdings
Company Website: https://www.perspectum.com/
Software Category: Medical Imaging Solutions
About the Company: Perspectum, a global medical technology company with offices in the US, UK, Portugal, and Singapore, delivers leading digital technologies that help clinicians provide better care for patients with chronic metabolic diseases, multi-organ pathology, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, its vision is to empower patients and clinicians through quantitative assessments of health, enabling early detection, diagnosis, and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers, and technologists, Perspectum offers a way to manage complex health problems at scale.